Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV000660587 | SCV000782699 | likely pathogenic | not provided | 2024-08-06 | criteria provided, single submitter | clinical testing | PP3, PM2, PM3, PS4_moderate |
Gene |
RCV000660587 | SCV001772512 | likely pathogenic | not provided | 2023-08-30 | criteria provided, single submitter | clinical testing | Observed in unrelated patients with KARS1-related aminoacyl-tRNA synthetase deficiency in published literature (Schon et al., 2021; Macken et al., 2022); however it is unclear whether the variants are on the same allele (in cis) or on opposite alleles (in trans); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34172899, 36344503, 34732400) |
Medical Genetics, |
RCV003322806 | SCV004028475 | likely pathogenic | Leukoencephalopathy, progressive, infantile-onset, with or without deafness | 2023-08-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026058 | SCV004888891 | uncertain significance | not specified | 2022-05-11 | criteria provided, single submitter | clinical testing | The c.774A>T (p.R258S) alteration is located in exon 7 (coding exon 6) of the KARS gene. This alteration results from a A to T substitution at nucleotide position 774, causing the arginine (R) at amino acid position 258 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |